Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Issuer Symbol
-
ATYR on Nasdaq
Jill Marie Broadfoot - trading volume in the past year for aTYR PHARMA INC
Holdings reported by Jill Marie Broadfoot for aTYR PHARMA INC
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
35,104 |
$27,753 |
$0.7906 |
09 Jan 2026 |
Direct |
|
|
| Restricted Stock Unit |
3,750 |
$14,175 |
$3.78 |
03 Feb 2025 |
Direct |
Common Stock |
|
| Employee Stock Option (right to buy) |
412,500 |
|
|
09 Jan 2026 |
Direct |
Common Stock |
|
Transactions reported by Jill Marie Broadfoot for aTYR PHARMA INC
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.